Back to Search
JANE O'SHAUGHNESSY, M.D.
M.D.
Emergency Medicine Physician
NPI: 1700156460Individual
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
122403(NY)
Research & Publications (20)
What lessons do coming out as gay men or lesbians have for people stigmatized by mental illness?
PMID 19263219·Community Ment Health J·2009
8-other
Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer.
PMID 19459042·Breast Cancer Res Treat·2009
3-trial
Workshop report and follow-up--AAPS Workshop on current topics in GLP bioanalysis: Assay reproducibility for incurred samples--implications of Crystal City recommendations.
PMID 19381839·AAPS J·2009
6-review
Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
PMID 19349550·J Clin Oncol·2009
3-trial
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.
PMID 19204201·J Clin Oncol·2009
3-trial
The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer.
PMID 19139988·Breast Cancer Res Treat·2009
8-other
Novel taxane formulations in the treatment of breast cancer: a thought leader discussion and consensus roundtable.
PMID 18501057·Clin Breast Cancer·2008
6-review
RiBBON 1 and RiBBON 2: phase III trials of bevacizumab with standard chemotherapy for metastatic breast cancer.
PMID 18757267·Clin Breast Cancer·2008
8-other
Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment.
PMID 18711184·J Clin Oncol·2008
3-trial
Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer.
PMID 18621615·Clin Breast Cancer·2008
3-trial
Synthesis by radical cyclization and cytotoxicity of highly potent bioreductive alicyclic ring fused [1,2-a]benzimidazolequinones.
PMID 17200920·Chemistry·2007
8-other
Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes.
PMID 18269774·Clin Breast Cancer·2007
3-trial
Management of febrile neutropenia and cardiac toxicity in the adjuvant treatment of breast cancer.
PMID 18282366·Clin Breast Cancer·2007
6-review
Evaluation of an intervention aimed at improving voluntary incident reporting in hospitals.
PMID 17545341·Qual Saf Health Care·2007
2-rct
Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: report of a Tamoxifen Exemestane Adjuvant Multicenter trial substudy.
PMID 17947724·J Clin Oncol·2007
4-observational
Cardiac toxicity of trastuzumab-related regimens in HER2-overexpressing breast cancer.
PMID 17592672·Clin Breast Cancer·2007
6-review
Phase II trial of capecitabine and weekly paclitaxel in patients with metastatic breast cancer previously treated with every-3-week taxane therapy.
PMID 17386123·Clin Breast Cancer·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 201 W 89TH ST, APT 11A
NEW YORK, NY 10024 - Phone
- (212) 873-5963
Quick Facts
- NPI
- 1700156460
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile